Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-02 Sale |
2023-03-06 6:26 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
16,738 | $6.2476 | $104,572 | 103,513 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:26 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
11,833 | $6.2636 | $74,117 | 117,540 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:25 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
44,964 | $6.2404 | $280,594 | 1,476,902 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:25 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
13,934 | $6.2684 | $87,344 | 139,561 (Indirect Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:24 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
16,777 | $6.2338 | $104,584 | 205,980 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-16 4:38 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
8,000 | $7.0087 | $56,070 | 87,551 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-07 5:58 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
95,900 | $10.62 | $1,018,282 | 1,482,231 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-07 5:56 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
4,792 | $10.61 | $50,827 | 120,795 (Indirect Direct) |
View |
| 2022-08-22 Sale |
2022-08-23 5:01 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,605 | $10.27 | $37,007 | 96,673 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 4:06 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
8,300 | $10.3 | $85,504 | 95,551 (Direct) |
View |
| 2022-07-28 Sale |
2022-08-01 4:45 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
2,239 | $10.97 | $24,562 | 118,087 (Indirect Direct) |
View |
| 2022-06-13 Sale |
2022-06-14 8:37 pm |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
2,700 | $9.4789 | $25,593 | 6,515 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-03 4:31 pm |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
6,441 | $9.902 | $63,779 | 63,064 (Direct) |
View |
| 2022-05-31 Sale |
2022-06-02 4:47 pm |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
6,500 | $9.8542 | $64,052 | 68,387 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-02 9:29 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
12,060 | $11.09 | $133,779 | 181,351 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-02 9:28 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
6,974 | $11.19 | $78,060 | 177,778 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:27 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
37,096 | $11.16 | $413,959 | 1,627,766 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:27 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
12,305 | $11.26 | $138,513 | 197,826 (Indirect Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:26 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
15,601 | $11.25 | $175,492 | 266,307 (Direct) |
View |
| 2021-11-30 Sale |
2021-12-02 4:31 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
96,200 | $16.25 | $1,563,623 | 1,346,538 (Direct) |
View |
| 2021-09-15 Sale |
2021-09-17 08:52 am |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
16,824 | $16.49 | $277,394 | 162,362 (Direct) |
View |
| 2021-09-09 Sale |
2021-09-13 4:40 pm |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
19,109 | $16.74 | $319,976 | 31,091 (Direct) |
View |
| 2021-08-20 Sale |
2021-08-23 4:36 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,650 | $15.39 | $56,190 | 74,552 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-17 4:31 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
3,715 | $16.15 | $59,989 | 83,211 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-12 4:19 pm |
N/A 2033-06-07 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
51,267 | $0 | 69,788 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:19 pm |
N/A 2033-06-07 |
Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director |
51,267 | $0 | 77,675 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:18 pm |
N/A 2033-06-07 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
51,267 | $0 | 131,660 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:17 pm |
N/A 2033-06-07 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
51,267 | $0 | 76,198 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:50 pm |
N/A 2033-03-14 |
Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director |
77,684 | $0 | 77,684 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:11 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
110,200 | $0 | 197,751 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:11 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
110,200 | $0 | 206,873 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:10 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
390,000 | $0 | 1,796,866 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:09 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
110,200 | $0 | 230,995 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:08 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
110,200 | $0 | 300,257 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 5:58 pm |
N/A 2022-12-06 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
150,000 | $0 | 1,482,231 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 5:58 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
150,000 | $3.12 | 1,482,231 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-07 5:56 pm |
N/A 2022-12-06 |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
7,500 | $0 | 120,795 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-07 5:56 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
7,500 | $3.12 | 120,795 (Direct) |
View |
| 2022-08-26 Exercise |
2022-08-29 5:02 pm |
N/A 2022-12-06 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
1,250 | $0 | 190,057 (Direct) |
View |
| 2022-08-26 Exercise |
2022-08-29 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
1,250 | $3.12 | 190,057 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:55 pm |
N/A 2032-06-15 |
Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director |
36,713 | $0 | 46,713 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:55 pm |
N/A 2032-06-15 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
36,713 | $0 | 43,228 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:54 pm |
N/A 2032-06-15 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
36,713 | $0 | 105,100 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:53 pm |
N/A 2032-06-15 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
36,713 | $0 | 49,638 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-03 4:31 pm |
N/A 2022-06-13 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $0 | 63,064 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-03 4:31 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $4.15 | 63,064 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-02 4:47 pm |
N/A 2022-06-13 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $0 | 68,387 (Direct) |
View |
| 2022-05-31 Exercise |
2022-06-02 4:47 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $4.15 | 68,387 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:29 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
110,200 | $0 | 181,351 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:28 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
110,200 | $0 | 177,778 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:27 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
390,000 | $0 | 1,627,766 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:27 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
110,200 | $0 | 197,826 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:26 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
110,200 | $0 | 266,307 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 4:31 pm |
N/A 2021-12-05 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
150,000 | $0 | 1,346,538 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 4:31 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
150,000 | $4.88 | 1,346,538 (Direct) |
View |
| 2021-09-15 Exercise |
2021-09-17 08:52 am |
N/A 2029-07-24 |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
12,119 | $0 | 162,362 (Direct) |
View |
| 2021-09-15 Exercise |
2021-09-17 08:52 am |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
4,277 | $12.27 | 162,362 (Direct) |
View |
| 2021-09-15 Exercise |
2021-09-17 08:52 am |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
7,842 | $11.32 | 162,362 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 4:40 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
19,109 | $0 | 31,091 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 4:40 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
5,985 | $10.57 | 31,091 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 4:40 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
13,124 | $12.7 | 31,091 (Direct) |
View |